Creatine Shows Promise as Potential Depression Treatment

Creatine, a widely used supplement for muscle growth, may have unexpected benefits in treating depression, according to recent research from the University of Ottawa. The study, published in Brain Medicine, explores how creatine could impact brain chemistry and potentially alleviate symptoms of major depressive disorder (MDD) and bipolar disorder during depressive episodes. Led by Bassam Jeryous Fares, a student at the Faculty of Medicine, the research team reanalyzed data from five randomized controlled trials involving nearly 240 participants across various countries including South Korea, the United States, Brazil, India, and Israel.

While the studies did not produce uniform results, two trials showed significant positive outcomes when creatine was combined with antidepressants or cognitive behavioral therapy. However, three other studies found no measurable benefits for patients who had previously failed to respond to conventional depression medications. One trial even reported adverse effects such as hypomania or mania in some bipolar participants.

The researchers highlight the importance of adenosine triphosphate (ATP) and its role in energy production within the brain, suggesting that creatine's ability to replenish ATP may influence mood disorders. Despite these intriguing findings, Fares cautions against immediate clinical application, emphasizing the need for further research to establish a clearer link between creatine supplementation and depression treatment efficacy.